Director · Prestige Consumer Healthcare Inc. (PBH)

James C. D'Arecca — Prestige Consumer Healthcare Director Compensation (2026)

Fiscal year 2026 director compensation for James C. D'Arecca at Prestige Consumer Healthcare Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed June 29, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Prestige Consumer Healthcare Director Compensation Table · the one fiscal year held
In US dollars, as Prestige Consumer Healthcare reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2026$115,000$155,040——$270,040

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Prestige Consumer Healthcare Inc. DEF 14A filed June 29, 2026, accession 0001295947-26-000021, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2026

Prestige Consumer Healthcare pays directors a $95,000 cash retainer and $155,000 in RSUs.

The rest of the Prestige Consumer Healthcare board

FY2026 · as the company reported each
DirectorRoleFY2026 total
Celeste A. ClarkIndependent Director$265,040
Dawn M. ZierIndependent Director$270,040
John E. ByomLead Independent Director$320,542
John F. KellyIndependent Director$250,040
Katherine A. HopkinsIndependent Director$250,040
Mr. ByomIndependent Director$320,542
Mr. KellyIndependent Director$250,040
Ms. HopkinsIndependent Director$250,040
Ronald M. LombardiChair of the Board$0

The full Prestige Consumer Healthcare compensation record

free company brief

This page is one director within Prestige Consumer Healthcare's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy